User profiles for A Sita-Lumsden

Ailsa Sita-Lumsden

consultant medical oncologist
Verified email at gstt.nhs.uk
Cited by 1853

[HTML][HTML] Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009

A Sita-Lumsden, D Short, I Lindsay, NJ Sebire… - British journal of …, 2012 - nature.com
Background: Post-molar pregnancy gestational trophoblastic tumours (GTT) have been
curable with chemotherapy treatment for over 50 years. Because of the rarity of the diagnosis, …

Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry

…, M Tagliamento, A Pous, A Sita-Lumsden… - JAMA …, 2022 - jamanetwork.com
Importance Whether the severity and mortality of COVID-19 in patients with cancer have
improved in terms of disease management and capacity is yet to be defined. Objective To test …

[HTML][HTML] Circulating microRNAs as potential new biomarkers for prostate cancer

A Sita-Lumsden, DA Dart, J Waxman… - British journal of …, 2013 - nature.com
Since they were first described in the 1990s, circulating microRNAs (miRNAs) have provided
an active and rapidly evolving area of current research that has the potential to transform …

Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight

A Sita-Lumsden, G Lapthorn, R Swaminathan… - Thorax, 2007 - thorax.bmj.com
Background: As well as its role in the regulation of calcium metabolism, vitamin D is an
immunoregulatory hormone. Epidemiological evidence also suggests a link between vitamin D …

Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer

CE Fletcher, DA Dart, A Sita-Lumsden… - Human molecular …, 2012 - academic.oup.com
MicroRNAs (miRs) play an important role in the development of many complex human diseases
and may have tumour suppressor or oncogenic (oncomir) properties. Prostate cancer is …

Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the …

…, T Newsom-Davis, J Handford, A Sita-Lumsden… - The Lancet …, 2022 - thelancet.com
Background The omicron (B.1.1.529) variant of SARS-CoV-2 is highly transmissible and
escapes vaccine-induced immunity. We aimed to describe outcomes due to COVID-19 during …

The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome

PM Savage, A Sita-Lumsden, S Dickson… - Journal of Obstetrics …, 2013 - Taylor & Francis
The national registration and treatment service for molar pregnancies in the UK allows for
the collection of accurate data on this relatively rare diagnosis. In England and Wales, …

[HTML][HTML] Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London

…, F Cahill, A Haire, K Zaki, A Sita-Lumsden… - British journal of …, 2021 - nature.com
Background Using an updated dataset with more patients and extended follow-up, we further
established cancer patient characteristics associated with COVID-19 death. Methods Data …

[HTML][HTML] Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the …

…, M Tagliamento, A Pous, A Sita-Lumsden… - The Lancet …, 2021 - thelancet.com
Background The medium-term and long-term impact of COVID-19 in patients with cancer is
not yet known. In this study, we aimed to describe the prevalence of COVID-19 sequelae and …

[HTML][HTML] Revising the role of the androgen receptor in breast cancer

FM Fioretti, A Sita-Lumsden… - Journal of molecular …, 2014 - jme.bioscientifica.com
Breast cancer (BC) is traditionally viewed as an oestrogen-dependent disease in which the
androgen receptor (AR) is inhibitory, counteracting the oncogenic activity of oestrogen …